Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda

被引:73
作者
Nasuuna, Esther [1 ]
Kigozi, Joanita [1 ]
Babirye, Lillian [1 ]
Muganzi, Alex [1 ]
Sewankambo, Nelson K. [2 ]
Nakanjako, Damalie [1 ,2 ]
机构
[1] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, POB 22418, Kampala, Uganda
[2] Makerere Univ, Coll Hlth Sci, Sch Med, POB 7072, Kampala, Uganda
基金
英国惠康基金;
关键词
Detectable viral load; Viral load monitoring; Intensive adherence counseling (IAC); Adolescents; Pediatric; Uganda; Antiretroviral therapy; ANTIRETROVIRAL THERAPY; MEDICATION ADHERENCE; PREDICTORS; INFECTION; TANZANIA; OUTCOMES; SUPPORT; AFRICA; ADULTS; LOAD;
D O I
10.1186/s12889-018-5964-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The UNAIDS 90-90-90 strategy clearly stipulates that 90% of all people on antiretroviral therapy (ART) should have a suppressed viral load. Intensified adherence counselling (IAC) was recently recommended by WHO to improve viral suppression among ART-treated paediatric and adolescent clients with virological failure. This paper describes the implementation and outcomes of IAC in the first year of implementation in a public ART program, to inform strategic interventions to reach the "third 90" among children. Methods: A retrospective chart review was conducted for all children aged 9 months to 19 years with HIV viral loads (VL) >= 1000 copies/ml at 15 public health facilities from June 2015-December 2016. Data on initial VL test results, IAC sessions, repeat VL test results, and ART regimen switch were abstracted and analysed for completion of IAC and viral suppression after IAC. Results: A total of 449 children had a detectable viral load above 1000 copies/ml, after an average of 3.5 years (SD 5.8) years of ART. 192 (43%) were 10-20 years of age, and 320 (71%) were receiving Nevirapine-based ART regimen. Out of 345 (77%) who completed the recommended three IAC sessions, 62 (23%) achieved viral suppression following IAC. The mean time from 1st to 3rd IAC session was 113 (SD 153) days and 172 (50%) of the children had completed the three sessions within 200 days. Conclusion: Suppression rates were low among ART-treated children with virological failure that completed the recommended three IAC sessions. As we move towards having 90% of ART-treated children and adolescents achieve and maintain viral suppression, there is need to re-evaluate the implementation of IAC among children and adolescents to consider both psychosocial and biological factors such as resistance testing for those with multiple detectable viral loads.
引用
收藏
页数:9
相关论文
共 30 条
[1]   Effects of leisure activities and psychosocial support on medication adherence and clinic attendance among children on antiretroviral therapy [J].
Anigilaje, Emmanuel Ademola ;
Dabit, Othniel Joseph ;
Tyovenda, Ruth Kashimana ;
Emebolu, Agnes Jane ;
Agbedeh, Augustine Aondohemba ;
Olutola, Ayodotun ;
Anigilaje, Omolara Olufunmilayo .
HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2014, 6 :127-137
[2]   Interventions to improve adherence to antiretroviral therapy in children with HIV infection [J].
Bain-Brickley, Deborah ;
Butler, Lisa M. ;
Kennedy, Gail E. ;
Rutherford, George W. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12)
[3]   Paediatric HIV treatment failure: a silent epidemic [J].
Bernheimer, Jonathan M. ;
Patten, Gem ;
Makeleni, Thembisa ;
Mantangana, Nompumelelo ;
Dumile, Nombasa ;
Goemaere, Eric ;
Cox, Vivian .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
[4]   Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda [J].
Bikaako-Kajura, Winnie ;
Luyirika, Emmanuel ;
Purcell, David W. ;
Downing, Julia ;
Kaharuza, Frank ;
Mermin, Jonathan ;
Malamba, Samuel ;
Bunnell, Rebecca .
AIDS AND BEHAVIOR, 2006, 10 (Suppl 1) :S85-S93
[5]  
Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac
[6]   Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015 [J].
Bulage, Lilian ;
Ssewanyana, Isaac ;
Nankabirwa, Victoria ;
Nsubuga, Fred ;
Kihembo, Christine ;
Pande, Gerald ;
Ario, Alex R. ;
Matovu, Joseph K. B. ;
Wanyenze, Rhoda K. ;
Kiyaga, Charles .
BMC INFECTIOUS DISEASES, 2017, 17
[7]   Longitudinal Antiretroviral Adherence in HIV plus Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Role of Depression in Declining Adherence Over Time [J].
Byakika-Tusiime, Jayne ;
Crane, Johanna ;
Oyugi, Jessica H. ;
Ragland, Kathleen ;
Kawuma, Annet ;
Musoke, Philippa ;
Bangsberg, David R. .
AIDS AND BEHAVIOR, 2009, 13 :S82-S91
[8]  
Davies Mary-Ann, 2015, J Int AIDS Soc, V18, P20770, DOI 10.7448/IAS.18.7.20770
[9]   Virologic Failure and Second-Line Antiretroviral Therapyin Children in South Africa-The IeDEA Southern Africa Collaboration [J].
Davies, Mary-Ann ;
Moultrie, Harry ;
Eley, Brian ;
Rabie, Helena ;
Van Cutsem, Gilles ;
Giddy, Janet ;
Wood, Robin ;
Technau, Karl ;
Keiser, Olivia ;
Egger, Matthias ;
Boulle, Andrew .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (03) :270-278
[10]   Caregiver-reported adherence to antiretroviral therapy among HIV infected children in Mekelle, Ethiopia [J].
Eticha, Tadele ;
Berhane, Lwam .
BMC PEDIATRICS, 2014, 14